ROYALTY PHARMA

Royalty Pharma owns a diversified portfolio of biotechnology product royalties and intellectual properties. Royalty Pharma has grown through the acquisition of revenue producing intellectual property – principally, royalty interests in marketed and late stage development biopharmaceutical products.